ALKS

#960
Alkermes plc - Ordinary Shares
42.2 0 USD
+5.66%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
42.10
42.81
Faixa anual
25.16
42.81
Mudança diária
+5.66%
Mudança mensal
+24.52%
Mudança em 6 meses
+44.03%
Mudança anual
+39.50%
Fechamento anterior
39.9 4
Open
42.4 6
Mínimo
42.1 0
High
42.8 1
Volume
2 644
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26

Alkermes plc - Ordinary Shares

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

Notícias